Truscreen Group Ltd
Company Profile
Business description
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening system which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.
Contact
C/- HLB Mann Judd Limited
57 Symonds Street
Level 6, Equitable House
Grafton
Auckland1010
NZLSector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2025
Employees
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,489.20 | 24.20 | 0.29% |
CAC 40 | 7,393.76 | 13.02 | 0.18% |
DAX 40 | 20,024.66 | 115.52 | 0.58% |
Dow JONES (US) | 42,392.27 | 151.95 | -0.36% |
FTSE 100 | 8,260.09 | 87.07 | 1.07% |
HKSE | 19,623.32 | 436.63 | -2.18% |
NASDAQ | 19,280.79 | 30.00 | -0.16% |
Nikkei 225 | 39,894.54 | 386.62 | -0.96% |
NZX 50 Index | 13,016.31 | 94.43 | -0.72% |
S&P 500 | 5,868.55 | 13.08 | -0.22% |
S&P/ASX 200 | 8,227.60 | 26.40 | 0.32% |
SSE Composite Index | 3,262.56 | 89.20 | -2.66% |